NCT06535802 iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men
| NCT ID | NCT06535802 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Prostate Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 53 participants |
| Start Date | 2023-11-20 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 53 participants in total. It began in 2023-11-20 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to determine the acceptance and effectiveness of a virtual robot assistant model at a urology clinic.
Eligibility Criteria
Inclusion Criteria: * AIM 1: iCCaRE Consortium consumer advocates * Clinicians who are part of the Translational Research \& Clinical Intervention Services (TRaCIS) * AIM 2 ALPHA TESTING: iCCaRE consumer advocates \[2 Community Advisory Board (CAB) and 1 non-CAB\] * AIM 2 BETA TESTING-PATIENTS: * An African American/Black male * A patient who has been diagnosed with prostate cancer in Florida at any time in their life, and/or within the previous 6 months has had an abnormal Prostate-Specific Antigen (PSA) lab value and/or Digital Rectal Examination (DRE) * Minimum age of 30 years old * Consent to participating in the intervention Exclusion Criteria: * AIM 2 BETA TESTING-PATIENTS: * Patients who are not African American/Black males * Patients not diagnosed with prostate cancer in Florida at any time in their life, or within the previous 6 months has not had a normal PSA lab value and/or DRE * Older than 80 years old * Are not willing to consent
Contact & Investigator
Folakemi T. Odedina, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06535802 clinical trial?
This trial is open to participants of all sexes, up to 80 Years, studying Prostate Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06535802 currently recruiting?
Yes, NCT06535802 is actively recruiting participants. Visit ClinicalTrials.gov or contact Mayo Clinic to inquire about joining.
Where is the NCT06535802 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT06535802 clinical trial?
NCT06535802 is sponsored by Mayo Clinic. The principal investigator is Folakemi T. Odedina, PhD at Mayo Clinic. The trial plans to enroll 53 participants.